MOOD AND ANXIETY DISORDERS PROGRAM

Combining a Dopamine Agonist and Selective Serotonin Reuptake Inhibitor for Treatment of Depression: A Double-Blind, Randomized Study

Investigation of the Rapid (Next Day) Antidepressant Effects of an NMDA Antagonist

Neural Correlates of Depressive Symptoms and Reward Related Mechanisms Following AMPT Depletion in Remitted Depressed Patients Off Treatment and Healthy Controls

Yohimbine to Induce Rapid Antidepressant Effects

FMRI Study of Performance During a Probabilistic Reversal Learning Task in Depression

Neuroanatomy of Emotion Regulation in Major Depressive Disorder

An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907 in Combination with Escitalopram in Treatment Resistant Depression

The Functional Neuroanatomy of Emotion Regulation in Major Depressive Disorder (MDD)

Brain Regulation of Emotions in People with Depression and Anhedonia

Cholinergic Modulation of Cognition and Emotion in Mood Disorders: Functional Neuroimaging Studies

Bone Density and Depression.

Major Depression and Brain Imaging.

Understanding Serotonin and Benzodiazepine Receptors in Panic Disorder, PTSD, and Depression

Reward and Brain Function

Muscarinic Cholinergic Receptor Imaging in Depression

For more information on Depression in Adults visit:

NIMH Depression Information Site

National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892

Department of Health and Human Services

This page was last updated: 03/18/2005.